687 related articles for article (PubMed ID: 32325683)
1. Metabolic Regulation of Myeloid-Derived Suppressor Cell Function in Cancer.
Wang Y; Jia A; Bi Y; Wang Y; Liu G
Cells; 2020 Apr; 9(4):. PubMed ID: 32325683
[TBL] [Abstract][Full Text] [Related]
2. Lipid Metabolic Pathways Confer the Immunosuppressive Function of Myeloid-Derived Suppressor Cells in Tumor.
Yan D; Adeshakin AO; Xu M; Afolabi LO; Zhang G; Chen YH; Wan X
Front Immunol; 2019; 10():1399. PubMed ID: 31275326
[TBL] [Abstract][Full Text] [Related]
3. A Complex Metabolic Network Confers Immunosuppressive Functions to Myeloid-Derived Suppressor Cells (MDSCs) within the Tumour Microenvironment.
Hofer F; Di Sario G; Musiu C; Sartoris S; De Sanctis F; Ugel S
Cells; 2021 Oct; 10(10):. PubMed ID: 34685679
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Reprogramming of Myeloid-derived Suppressor Cells in the Tumor Microenvironment.
Liu L; Huo S; Liu J; Li Q; Wang J
Discov Med; 2021; 31(164):141-146. PubMed ID: 35188888
[TBL] [Abstract][Full Text] [Related]
5. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
Qu P; Wang LZ; Lin PC
Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
[TBL] [Abstract][Full Text] [Related]
6. β2-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME.
Mohammadpour H; MacDonald CR; McCarthy PL; Abrams SI; Repasky EA
Cell Rep; 2021 Oct; 37(4):109883. PubMed ID: 34706232
[TBL] [Abstract][Full Text] [Related]
7. Glycolysis regulates the expansion of myeloid-derived suppressor cells in tumor-bearing hosts through prevention of ROS-mediated apoptosis.
Jian SL; Chen WW; Su YC; Su YW; Chuang TH; Hsu SC; Huang LR
Cell Death Dis; 2017 May; 8(5):e2779. PubMed ID: 28492541
[TBL] [Abstract][Full Text] [Related]
8. AMPK activation inhibits the functions of myeloid-derived suppressor cells (MDSC): impact on cancer and aging.
Salminen A; Kauppinen A; Kaarniranta K
J Mol Med (Berl); 2019 Aug; 97(8):1049-1064. PubMed ID: 31129755
[TBL] [Abstract][Full Text] [Related]
9. mTOR-mediated glycolysis contributes to the enhanced suppressive function of murine tumor-infiltrating monocytic myeloid-derived suppressor cells.
Deng Y; Yang J; Luo F; Qian J; Liu R; Zhang D; Yu H; Chu Y
Cancer Immunol Immunother; 2018 Sep; 67(9):1355-1364. PubMed ID: 29968153
[TBL] [Abstract][Full Text] [Related]
10. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
[TBL] [Abstract][Full Text] [Related]
11. Connections between Metabolism and Epigenetic Modification in MDSCs.
Dai H; Xu H; Wang S; Ma J
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027968
[TBL] [Abstract][Full Text] [Related]
12. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
De Cicco P; Ercolano G; Ianaro A
Front Immunol; 2020; 11():1680. PubMed ID: 32849585
[TBL] [Abstract][Full Text] [Related]
13. Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression.
Chen Z; Yuan R; Hu S; Yuan W; Sun Z
Front Immunol; 2022; 13():817942. PubMed ID: 35154134
[TBL] [Abstract][Full Text] [Related]
14. The downregulation of type I IFN signaling in G-MDSCs under tumor conditions promotes their development towards an immunosuppressive phenotype.
Sun Y; Han X; Shang C; Wang Y; Xu B; Jiang S; Mo Y; Wang D; Ke Y; Zeng X
Cell Death Dis; 2022 Jan; 13(1):36. PubMed ID: 35013108
[TBL] [Abstract][Full Text] [Related]
15. Energy metabolism manipulates the fate and function of tumour myeloid-derived suppressor cells.
Hu C; Pang B; Lin G; Zhen Y; Yi H
Br J Cancer; 2020 Jan; 122(1):23-29. PubMed ID: 31819182
[TBL] [Abstract][Full Text] [Related]
16. The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment.
Mi Y; Guo N; Luan J; Cheng J; Hu Z; Jiang P; Jin W; Gao X
Front Immunol; 2020; 11():737. PubMed ID: 32391020
[TBL] [Abstract][Full Text] [Related]
17. Indoleamine 2,3-dioxygenase regulates anti-tumor immunity in lung cancer by metabolic reprogramming of immune cells in the tumor microenvironment.
Schafer CC; Wang Y; Hough KP; Sawant A; Grant SC; Thannickal VJ; Zmijewski J; Ponnazhagan S; Deshane JS
Oncotarget; 2016 Nov; 7(46):75407-75424. PubMed ID: 27705910
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
Front Immunol; 2020; 11():585214. PubMed ID: 33613512
[TBL] [Abstract][Full Text] [Related]
19. Blocking Monocytic Myeloid-Derived Suppressor Cell Function via Anti-DC-HIL/GPNMB Antibody Restores the
Kobayashi M; Chung JS; Beg M; Arriaga Y; Verma U; Courtney K; Mansour J; Haley B; Khan S; Horiuchi Y; Ramani V; Harker D; Gopal P; Araghizadeh F; Cruz PD; Ariizumi K
Clin Cancer Res; 2019 Jan; 25(2):828-838. PubMed ID: 30049749
[TBL] [Abstract][Full Text] [Related]
20. Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy.
Zalfa C; Paust S
Front Immunol; 2021; 12():633205. PubMed ID: 34025641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
